Loading
institutionsInstitution
Krankenhaus Nordwest / Institute of Clinical Cancer Research (IKF)
Frankfurt teaching hospital whose Institute of Clinical Cancer Research ran FLOT4, the trial that made FLOT chemotherapy the standard before and after surgery for stomach cancer.
Also called: Institut für Klinisch-Onkologische ForschungIKF FrankfurtUCT Frankfurt partner hospital
Overview
Krankenhaus Nordwest is a teaching hospital of Goethe University in the north-west of Frankfurt. Its Institute of Clinical Cancer Research (IKF), directed by Salah-Eddin Al-Batran, is a trial office for the German AIO cooperative group in gastrointestinal cancer and coordinated the FLOT4 trial, whose 2019 Lancet report established perioperative FLOT for resectable gastric and gastro-oesophageal junction adenocarcinoma. The hospital is a partner site of the University Cancer Center Frankfurt.
Location
Frankfurt am Main, DE
Type
hospital
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#402 · 14 points (0 Newsweek + 0 NCI + 14 from 7 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Krankenhaus Nordwest, including child institutions. 109 works · 1,474 citations · 80% open access · 28% clinical trials · 1% reviews.
Oncology works per year
152022
172023
202024
312025
262026
Most works
- Thorsten Oliver Goetze34 works
- Akin Atmaca16 works
- Claudia Pauligk15 works
- Ralf‐Dieter Hofheinz11 works
- S-E. Al-Batran10 works
- Dominik Paul Modest10 works
- Salah‐Eddin Al‐Batran10 works
- Alexander Stein10 works
- Roberto Pazo-Cid9 works
- Zev A. Wainberg9 works
Most cited
- Gastro-oesophageal cancer trials (AIO)
- Perioperative chemotherapy
Similar pages
- Key paperNeoadjuvant treatment for incidental gallbladder cancer: A systematic review
Shares Chemotherapy before the second operation for high-risk incidental gallbladder cancer, GAIN (AIO/CALGP/ACO).
- Key paperFLOT4-AIO: perioperative FLOT versus ECF/ECX for resectable gastric or gastro-oesophageal junction adenocarcinoma
Shares Salah-Eddin Al-Batran, FLOT4-AIO.
- PersonFlorian R. Greten
Shares University Cancer Center Frankfurt (UCT), Gastric & gastro-oesophageal junction cancer.
- CompanyAIO (Arbeitsgemeinschaft Internistische Onkologie)
Shares FLOT4-AIO, Oesophageal cancer, Gastric & gastro-oesophageal junction cancer.
- TrialOPT-IN (EA2197)
Shares Chemotherapy before the second operation for high-risk incidental gallbladder cancer, GAIN (AIO/CALGP/ACO).
- CancerIncidental gallbladder cancer (found after cholecystectomy)
Shares Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial, Chemotherapy before the second operation for high-risk incidental gallbladder cancer.
- TermRadical (extended) cholecystectomy
Shares Chemotherapy before the second operation for high-risk incidental gallbladder cancer, GAIN (AIO/CALGP/ACO).